InvestorsHub Logo
Followers 79
Posts 24434
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 10/16/2019 8:43:07 AM

Wednesday, October 16, 2019 8:43:07 AM

Post# of 27336
ATOS - 1.75 Pre-market now at 2.15/2.19

Atossa Genetics Receives IRB Approval for Phase 2 Breast Cancer Study Using Intraductal Technology

https://www.tradescores.com/StockReport/atos

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.